ACOT8 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-ACOT8 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ACOT8 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.05 mL, 0.1 mL |
| Concentration | 1.0 mg/ml |
| Applications | Western Blot (WB), Immunofluorescence (IF) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The antibody detects endogenous levels of total ACOT8 protein. Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. May mediate Nef-induced down-regulation of CD4. Major thioesterase in peroxisomes. Competes with BAAT (Bile acid CoA: amino acid N-acyltransferase) for bile acid-CoA substrate (such as chenodeoxycholoyl-CoA). Shows a preference for medium-length fatty acyl-CoAs By similarity. May be involved in the metabolic regulation of peroxisome proliferation.Watanabe H., Biochem. Biophys. Res. Commun. 238:234-239(1997).Liu L.X., J. Biol. Chem. 272:13779-13785(1 |
| Immunogen | Immunogen Type: Peptide Immunogen Description: Synthesized peptide derived from internal of human ACOT8. |
| Other Names | [ACTE-III; ACTEIII; acyl-CoA thioesterase 8; acyl-coenzyme A thioesterase 8; choloyl-coenzyme A thioesterase] |
| Gene, Accession # | [ACOT8], Gene ID: 10005, NCBI: NP_005460.2, UniProt: O14734 |
| Catalog # | MBS9402185 |
| Price | $200, $255 |
| Order / More Info | ACOT8 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies